NO20033670L - 2-indanylaminoderivater for behandling av kronisk smerte - Google Patents
2-indanylaminoderivater for behandling av kronisk smerteInfo
- Publication number
- NO20033670L NO20033670L NO20033670A NO20033670A NO20033670L NO 20033670 L NO20033670 L NO 20033670L NO 20033670 A NO20033670 A NO 20033670A NO 20033670 A NO20033670 A NO 20033670A NO 20033670 L NO20033670 L NO 20033670L
- Authority
- NO
- Norway
- Prior art keywords
- indanylamino
- treatment
- derivatives
- chronic pain
- pain
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title abstract 3
- -1 2-indanylamino Chemical class 0.000 title abstract 2
- 208000000094 Chronic Pain Diseases 0.000 title abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- MNLULKBKWKTZPE-UHFFFAOYSA-N indantadol Chemical compound C1=CC=C2CC(NCC(=O)N)CC2=C1 MNLULKBKWKTZPE-UHFFFAOYSA-N 0.000 abstract 1
- 210000005036 nerve Anatomy 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 206010044652 trigeminal neuralgia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01130638A EP1321139B1 (fr) | 2001-12-21 | 2001-12-21 | Dérivés du 2-indanylamine pour la thérapie de douleurs chroniques, aigues ou inflammatoires |
| PCT/EP2002/013839 WO2003053429A2 (fr) | 2001-12-21 | 2002-12-06 | Derives de 2-indanyl-amino utilises pour le traitement des douleurs chroniques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20033670D0 NO20033670D0 (no) | 2003-08-19 |
| NO20033670L true NO20033670L (no) | 2003-10-21 |
Family
ID=8179649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20033670A NO20033670L (no) | 2001-12-21 | 2003-08-19 | 2-indanylaminoderivater for behandling av kronisk smerte |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050222266A1 (fr) |
| EP (2) | EP1321139B1 (fr) |
| JP (1) | JP4427329B2 (fr) |
| AT (1) | ATE336990T1 (fr) |
| BR (1) | BR0207371A (fr) |
| CA (1) | CA2470990C (fr) |
| DE (1) | DE60122541T2 (fr) |
| DK (1) | DK1321139T3 (fr) |
| ES (1) | ES2270947T3 (fr) |
| HU (1) | HUP0402664A3 (fr) |
| MX (1) | MXPA04005884A (fr) |
| NO (1) | NO20033670L (fr) |
| NZ (1) | NZ533537A (fr) |
| PL (1) | PL207015B1 (fr) |
| PT (1) | PT1321139E (fr) |
| SI (1) | SI1321139T1 (fr) |
| WO (1) | WO2003053429A2 (fr) |
| ZA (1) | ZA200404845B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080287480A1 (en) * | 2005-07-28 | 2008-11-20 | Chiesi Farmaceutici S.P.A. | Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance |
| EP3970723A1 (fr) | 2011-02-18 | 2022-03-23 | Asana BioSciences, LLC | Composés aminoindane pour utilisation dans le traitement de douleurs urologiques |
| TWI603957B (zh) | 2012-08-15 | 2017-11-01 | 阿沙納生物科學有限責任公司 | 胺基氫茚化合物用於治療膀胱過動症及間質性膀胱炎之用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2115792C (fr) * | 1993-03-05 | 2005-11-01 | David J. Mayer | Methode de traitement de la douleur |
| IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
| EP0980247A1 (fr) * | 1997-05-07 | 2000-02-23 | Algos Pharmaceutical Corporation | Composition et methode associant un antidepresseur et un antagoniste de recepteur nmda pour traiter la douleur neuropathique |
| WO2000076510A1 (fr) * | 1999-06-10 | 2000-12-21 | Bridge Pharma, Inc. | Agents anesthesiques dermiques |
-
2001
- 2001-12-21 PT PT01130638T patent/PT1321139E/pt unknown
- 2001-12-21 SI SI200130651T patent/SI1321139T1/sl unknown
- 2001-12-21 EP EP01130638A patent/EP1321139B1/fr not_active Expired - Lifetime
- 2001-12-21 AT AT01130638T patent/ATE336990T1/de active
- 2001-12-21 DK DK01130638T patent/DK1321139T3/da active
- 2001-12-21 ES ES01130638T patent/ES2270947T3/es not_active Expired - Lifetime
- 2001-12-21 DE DE60122541T patent/DE60122541T2/de not_active Expired - Lifetime
-
2002
- 2002-12-06 EP EP02790474A patent/EP1455771B1/fr not_active Expired - Lifetime
- 2002-12-06 WO PCT/EP2002/013839 patent/WO2003053429A2/fr not_active Ceased
- 2002-12-06 PL PL370763A patent/PL207015B1/pl not_active IP Right Cessation
- 2002-12-06 US US10/498,350 patent/US20050222266A1/en not_active Abandoned
- 2002-12-06 HU HU0402664A patent/HUP0402664A3/hu unknown
- 2002-12-06 BR BR0207371-4A patent/BR0207371A/pt not_active IP Right Cessation
- 2002-12-06 MX MXPA04005884A patent/MXPA04005884A/es active IP Right Grant
- 2002-12-06 CA CA2470990A patent/CA2470990C/fr not_active Expired - Fee Related
- 2002-12-06 JP JP2003554186A patent/JP4427329B2/ja not_active Expired - Fee Related
- 2002-12-06 NZ NZ533537A patent/NZ533537A/en not_active IP Right Cessation
-
2003
- 2003-08-19 NO NO20033670A patent/NO20033670L/no not_active Application Discontinuation
-
2004
- 2004-06-18 ZA ZA200404845A patent/ZA200404845B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1321139E (pt) | 2007-01-31 |
| ES2270947T3 (es) | 2007-04-16 |
| ATE336990T1 (de) | 2006-09-15 |
| DE60122541T2 (de) | 2007-09-13 |
| EP1321139B1 (fr) | 2006-08-23 |
| WO2003053429A2 (fr) | 2003-07-03 |
| MXPA04005884A (es) | 2004-11-01 |
| JP4427329B2 (ja) | 2010-03-03 |
| HUP0402664A2 (hu) | 2005-04-28 |
| WO2003053429A3 (fr) | 2003-07-31 |
| PL370763A1 (en) | 2005-05-30 |
| EP1321139A1 (fr) | 2003-06-25 |
| SI1321139T1 (sl) | 2007-02-28 |
| DK1321139T3 (da) | 2007-01-02 |
| NZ533537A (en) | 2006-08-31 |
| NO20033670D0 (no) | 2003-08-19 |
| AU2002366727A1 (en) | 2003-07-09 |
| BR0207371A (pt) | 2004-02-10 |
| US20050222266A1 (en) | 2005-10-06 |
| JP2005513101A (ja) | 2005-05-12 |
| CA2470990C (fr) | 2011-03-29 |
| EP1455771A2 (fr) | 2004-09-15 |
| DE60122541D1 (de) | 2006-10-05 |
| CA2470990A1 (fr) | 2003-07-03 |
| ZA200404845B (en) | 2006-07-26 |
| HUP0402664A3 (en) | 2012-05-29 |
| EP1455771B1 (fr) | 2006-11-08 |
| PL207015B1 (pl) | 2010-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200201012A1 (ru) | Способы стерилизации биологических материалов | |
| ATE405279T1 (de) | Immobilisierung und stabilisierung von viren | |
| WO2003101397A3 (fr) | Vaccins tetravalents contre la dengue | |
| ATE552854T1 (de) | Gezielte biozide | |
| MY141003A (en) | Materials and methods for treating viral infections with a cysteamine compound | |
| EA199900773A1 (ru) | Противомикробная профилактика и лечение заболеваний, вызванных вирусом иммунодефицита человека и другими инфекциями | |
| EA200400026A1 (ru) | Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтические применения и вещества для их синтеза | |
| EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
| ECSP045139A (es) | DERIVADOS DE ACETILENO QUE TIENEN ACTIVIDAD ANTAGONISTICA DE MGluR5 | |
| PT1543011E (pt) | Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina | |
| BRPI0417322A (pt) | combinações de substáncias ativas com propriedades inseticidas | |
| BRPI0410029B8 (pt) | composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto | |
| DE60230869D1 (de) | 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen | |
| DE60233251D1 (de) | 4,4-difluor-1,2,3,4-tetrahydro-5h-1-benzazepinderivate und deren salze | |
| DE50110618D1 (de) | Verwendung von MEK-Inhibitoren zur Herstellung eines Arzneimittels gegen Negativstrang-RNA-Viren Infektionen | |
| CL2004000261A1 (es) | Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica. | |
| AR021155A1 (es) | Tratamiento de desordenes neuroticos | |
| NO20033670L (no) | 2-indanylaminoderivater for behandling av kronisk smerte | |
| EA200500774A1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| WO2007076091A3 (fr) | Traitement d’infections virales utilisant un inhibiteur de facteur tissulaire | |
| DE602004030330D1 (de) | KRISTALLSTRUKTUR DER TRYPANOSOMA CRUZI PROLINE RACEMASE (TcPRACA) UND VERWENDUNG DAVON | |
| WO2004071462A3 (fr) | Procede et composition pour le traitement d'infections virales utilisant l'interaction tsg101-vps28 | |
| BR0211533A (pt) | Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas | |
| WO2002067951A3 (fr) | Utilisation de nucleosides 5-substitues et/ou de leurs promedicaments pour traiter des maladies infectieuses sans induire de resistance | |
| ECSP055588A (es) | Formas cristalinas de [4-carbamoil-1-(3-fluorobencil)-2,7-dihidroxi-7-metil-octil]-amida del ácido quinoxalina-2-carboxilico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |